摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl 4-[(6-chloro-2-pyridinyl)oxy]-1-piperidinecarboxylate | 442199-11-3

中文名称
——
中文别名
——
英文名称
tert-butyl 4-[(6-chloro-2-pyridinyl)oxy]-1-piperidinecarboxylate
英文别名
4-(6-chloropyridin-2-yloxy)piperidine-1-carboxylic acid tert-butyl ester;tert-butyl 4-[(6-chloro-2-pyridyl)oxy]-1-piperidinecarboxylate;tert-butyl 4-((6-chloropyridin-2-yl)oxy)piperidine-1-carboxylate;tert-butyl 4-(6-chloropyridin-2-yl)oxypiperidine-1-carboxylate
tert-butyl 4-[(6-chloro-2-pyridinyl)oxy]-1-piperidinecarboxylate化学式
CAS
442199-11-3
化学式
C15H21ClN2O3
mdl
——
分子量
312.796
InChiKey
KHHURUBOLSDHDX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    404.9±45.0 °C(Predicted)
  • 密度:
    1.206±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    51.7
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    [EN] (PIPERIDINYLOXY)PHENYL, (PIPERIDINYLOXY)PYRIDINYL, (PIPERIDINYLSULFANYL)PHENYL AND (PIPERIDINYLSULFANYL)PYRIDINYL COMPOUNDS AS 5-HT1F AGONISTS
    [FR] COMPOSES (PIPERIDINYLOXY)PHENYLE, (PIPERIDINYLOXY)PYRIDINYLE, (PIPERIDINYLSULFANYL)PHENYLE ET (PIPERIDINYLSULFANYL)PYRIDINYLE UTILISES COMME AGONISTES DES RECEPTEURS 5-HT1F
    摘要:
    本发明涉及公式1的化合物及其药用可接受的酸盐。本发明的化合物可用于激活5-HTIF受体,抑制神经蛋白外渗,并用于治疗或预防哺乳动物,尤其是人类的偏头痛。
    公开号:
    WO2004094380A1
  • 作为产物:
    描述:
    2,6-二氯吡啶 在 sodium hydride 作用下, 以 二甲基亚砜 为溶剂, 反应 12.33h, 以72%的产率得到tert-butyl 4-[(6-chloro-2-pyridinyl)oxy]-1-piperidinecarboxylate
    参考文献:
    名称:
    [EN] (PIPERIDINYLOXY)PHENYL, (PIPERIDINYLOXY)PYRIDINYL, (PIPERIDINYLSULFANYL)PHENYL AND (PIPERIDINYLSULFANYL)PYRIDINYL COMPOUNDS AS 5-HT1F AGONISTS
    [FR] COMPOSES (PIPERIDINYLOXY)PHENYLE, (PIPERIDINYLOXY)PYRIDINYLE, (PIPERIDINYLSULFANYL)PHENYLE ET (PIPERIDINYLSULFANYL)PYRIDINYLE UTILISES COMME AGONISTES DES RECEPTEURS 5-HT1F
    摘要:
    本发明涉及公式1的化合物及其药用可接受的酸盐。本发明的化合物可用于激活5-HTIF受体,抑制神经蛋白外渗,并用于治疗或预防哺乳动物,尤其是人类的偏头痛。
    公开号:
    WO2004094380A1
点击查看最新优质反应信息

文献信息

  • [EN] BICYCLIC GPR119 MODULATORS<br/>[FR] MODULATEURS DE GPR119 BICYCLIQUES
    申请人:LUPIN LTD
    公开号:WO2012069917A1
    公开(公告)日:2012-05-31
    The present invention relates to compounds of Formula (I) that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of GPR119 receptor activity. The invention also relates to the process for preparation of the compounds, pharmaceutical compositions thereof. The invention further relates to methods of treating, preventing and/or managing diseases, disorders syndromes or conditions associated with the modulation of GPR1 19 receptor by using either alone or in combinations of Formula (I).
    本发明涉及一种化合物(I)的公式,该化合物对治疗、预防和/或管理与调节GPR119受体活性相关的疾病、紊乱、综合征或病况有用。该发明还涉及制备这些化合物的方法、其药物组成物。此外,该发明还涉及利用单独或以公式(I)的组合物治疗、预防和/或管理与调节GPR119受体相关的疾病、紊乱、综合征或病况的方法。
  • Peptide compounds
    申请人:——
    公开号:US20040097425A1
    公开(公告)日:2004-05-20
    The present invention relates to a compound of the formula (I)wherein R1 is benzofuranyl substituted by halogen, or styryl substituted by halogen; R2 is substituted hydroxy, substituted mercapto or substituted sulfonyl; and X is or pharmaceutically acceptable salts thereof. The compound (1) of the present invention and pharmaceutically acceptable salts thereof possess a strong inhibitory activity on the production of nitric oxide (NO), and are useful for prevention and/or treatment of NO-mediated diseases in human being and animals. 1
    本发明涉及一种化合物,其化学式为(I),其中R1为被卤素取代的苯并呋喃基或被卤素取代的苯乙烯基;R2为取代羟基、取代巯基或取代磺酰基;X为或其药用可接受盐。本发明的化合物(1)及其药用可接受盐对一氧化氮(NO)的产生具有强烈的抑制活性,并可用于预防和/或治疗人类和动物体内的NO介导的疾病。
  • (Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists
    申请人:Blanco-Pillado Maria-Jesus
    公开号:US20060211734A1
    公开(公告)日:2006-09-21
    The present invention relates to compounds of formula 1: and pharmaceutically acceptable acid addition sails thereof. The compounds of the present invention are useful for activating 5-HT 1F receptors, inhibiting neuronal protein extravasation, and for the treatment or preverition of migraine in mammals, particularly humans.
    本发明涉及公式1的化合物及其药学上可接受的酸盐。本发明的化合物对于激活5-HT1F受体、抑制神经蛋白外渗以及治疗或预防哺乳动物,特别是人类的偏头痛具有用途。
  • Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound
    申请人:Ishii Takahiro
    公开号:US20100009971A1
    公开(公告)日:2010-01-14
    A novel pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound or its pharmaceutically acceptable salt has a potent FAAH-inhibitory activity. Further, the pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound of the present disclosure is also useful in the treatment of urinary frequency and urinary incontinence, overactive bladder and/or pain.
    一种新型的吡啶基非芳香性含氮杂环-1-羧酸酯化合物或其药学上可接受的盐具有强效的FAAH抑制活性。此外,本公开的吡啶基非芳香性含氮杂环-1-羧酸酯化合物也可用于治疗尿频、尿失禁、过度活跃的膀胱和/或疼痛。
  • Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative
    申请人:Ishii Takahiro
    公开号:US20080306046A1
    公开(公告)日:2008-12-11
    [Problem] To provide a compound usable for treatment of diseases associated with fatty acid amide hydrolase (FAAH), especially for treatment of urinary frequency and urinary incontinence, overactive bladder and/or pain. [Means for Solution] We have found that a novel pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative and its pharmaceutically acceptable salt has a potent FAAH-inhibitory activity. Further, the pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative of the present invention has an excellent effect for increasing an effective bladder capacity, an excellent effect for relieving urinary frequency and an excellent anti-allodynia effect, and is therefore usable for treatment of urinary frequency and urinary incontinence, overactive bladder and/or pain.
    [问题] 提供一种可用于治疗与脂肪酸酰胺水解酶(FAAH)相关的疾病的化合物,特别是用于治疗尿频和尿失禁、过度活跃的膀胱和/或疼痛。 [解决方法] 我们发现一种新型的吡啶基非芳香性含氮杂环-1-羧酸酯衍生物及其药学上可接受的盐具有强效的FAAH抑制活性。此外,本发明的吡啶基非芳香性含氮杂环-1-羧酸酯衍生物具有优异的增加有效膀胱容量的效果,优异的缓解尿频的效果和优异的抗痛觉过敏效果,因此可用于治疗尿频和尿失禁、过度活跃的膀胱和/或疼痛。
查看更多